Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of an absorbed acellular diphtheria-tetanus-pertussis component combined vaccine in 3-month-old infants
CTR20234036Phase 3Active
- Sponsor
- Zhifei Green Bamboo
- Start
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of absorbed acellular diphtheria-tetanus-pertussis (component) combined vaccine in pertussis, diphtheria, Tetanus, sponsored by Zhifei Green Bamboo. Started Dec 2023; status: active.
02
Drugs
absorbed acellular diphtheria-tetanus-pertussis (component) combined vaccine
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on CTR20234036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234036.